FELICIA MACKEY: Open Payments
NPI 1972239747 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,314 in 157 payments from 23 companies in 2025. Trend: 2023 $3,423 · 2024 $4,140 · 2025 $4,314
Food & beverage: $3,785Travel & lodging: $357Education: $172
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 29 | $775 |
| Inspire Medical Systems, Inc. | 5 | $567 |
| United Therapeutics Corporation | 17 | $438 |
| GlaxoSmithKline, LLC. | 22 | $404 |
| Astellas Pharma US Inc | 8 | $218 |
| JAZZ PHARMACEUTICALS INC. | 4 | $199 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $182 |
| Amgen Inc. | 13 | $171 |
| Pulmonx Corporation | 1 | $161 |
| Verona Pharma, Inc. | 7 | $159 |
Products named: INSPIRE, Tyvaso, FASENRA, NUCALA, BREZTRI, XYWAV, DUPIXENT, AmBisome.
Industry payments across CA — which companies pay providers there.
